Global Influenza Vaccines Market 2019-2028

MARKET OUTLOOK

According to an analysis, the global influenza vaccines market is predicted to grow at a CAGR of 6.20% during the forecasting period 2019-2028.
The rapid advancements in technology in the field of vaccine development are driving the growth of the global influenza vaccines market. Governments are increasingly taking several immunization programs focusing on raising awareness among the public regarding vaccinations. This factor is also aiding the global market growth.

However, the huge cost of development is restraining this growth. Moreover, the complex development process and stringent government regulations are also posing a challenge to growth. But, it is expected that the ever-increasing cases of influenza throughout the world will create opportunities for the studied market in the estimated period.

REGIONAL OUTLOOK

The global market report covers the countries from North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa.
Rising prevalence of influenza in countries like India, China and Japan is the main factor instigating the demand for better vaccination. This factor, along with the rising healthcare expenditure in these countries, is likely to boost the growth of the influenza vaccines market in the region. Government initiatives and funding towards the development of vaccines is also aiding the regional market growth. Besides, major players in this region are focusing on research & development activities in this filed to enhance their market presence.

COMPETITIVE OUTLOOK

The major companies in the influenza vaccines market are Merck Sharp & Dohme Corp, BioDiem, Novartis AG, Abbott, Pfizer Inc, CSL Limited, Emergent Biosolutions Inc, Sanofi, F. Hoffmann-La Roche Ltd and GlaxoSmithKline Plc.
With more than two decades of experience in the vaccine market, Emergent Biosolutions is a global biopharmaceutical company that offers specialized products to cater to medical needs. The company is focused on enhancing life by offering specialty products to civilian and military people. It focuses on the development, manufacturing and marketing of medical countermeasures to address public health threats. Uni-Flu is an influenza vaccine provided by the company.

1. Global Influenza Vaccines Market - Summary

2. Industry Outlook

2.1. Market Definition
2.2. Key Insights
2.2.1. Quadrivalent is the Dominant Type of Influenza Vaccine
2.2.2. Injection is Fastest-Growing Delivery Mode
2.2.3. Cell-Based Technology is Rapidly Growing Technology in the Market
2.2.4. Adult Age Group is Majorly Contributing in the Market
2.3. Porter's Five Force Analysis
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitute
2.3.3. Bargaining Power of Suppliers
2.3.4. Bargaining Power of Buyers
2.3.5. Intensity of Competitive Rivalry
2.4. Market Attractiveness Index
2.5. Vendor Scorecard
2.6. Market Drivers
2.6.1. Advancement in Technology
2.6.2. Initiatives Taken Up by the Government
2.7. Market Restraints
2.7.1. High Cost of Development
2.8. Market Opportunities
2.8.1. Growth in the Cases of Influenza
2.9. Market Challenges
2.9.1. Complex Development Process

3. Influenza Vaccines Market Outlook - by Type

3.1. Quadrivalent Vaccine
3.2. Trivalent Vaccine

4. Influenza Vaccines Market Outlook - by Technology

4.1. Egg-Based Technology
4.2. Cell-Based Technology

5. Influenza Vaccines Market Outlook - by Age Group

5.1. Pediatric Age Group
5.2. Adult Age Group

6. Influenza Vaccines Market Outlook - by Delivery Mode

6.1. Injection
6.2. Nasal Spray

7. Influenza Vaccines Market – Regional Outlook

7.1. North America
7.1.1. Market by Type
7.1.2. Market by Technology
7.1.3. Market by Age Group
7.1.4. Market by Delivery Mode
7.1.5. Country Analysis
7.1.5.1. United States
7.1.5.2. Canada
7.2. Europe
7.2.1. Market by Type
7.2.2. Market by Technology
7.2.3. Market by Age Group
7.2.4. Market by Delivery Mode
7.2.5. Country Analysis
7.2.5.1. United Kingdom
7.2.5.2. Germany
7.2.5.3. France
7.2.5.4. Spain
7.2.5.5. Italy
7.2.5.6. Russia
7.2.5.7. Rest of Europe
7.3. Asia-Pacific
7.3.1. Market by Type
7.3.2. Market by Technology
7.3.3. Market by Age Group
7.3.4. Market by Delivery Mode
7.3.5. Country Analysis
7.3.5.1. China
7.3.5.2. Japan
7.3.5.3. India
7.3.5.4. South Korea
7.3.5.5. Asean Countries
7.3.5.6. Australia & New Zealand
7.3.5.7. Rest of Asia-Pacific
7.4. Latin America
7.4.1. Market by Type
7.4.2. Market by Technology
7.4.3. Market by Age Group
7.4.4. Market by Delivery Mode
7.4.5. Country Analysis
7.4.5.1. Brazil
7.4.5.2. Mexico
7.4.5.3. Rest of Latin America
7.5. Middle East and Africa
7.5.1. Market by Type
7.5.2. Market by Technology
7.5.3. Market by Age Group
7.5.4. Market by Delivery Mode
7.5.5. Country Analysis
7.5.5.1. The United Arab Emirates
7.5.5.2. Turkey
7.5.5.3. Saudi Arabia
7.5.5.4. South Africa
7.5.5.5. Rest of Middle East & Africa

8. Competitive Landscape

8.1. Merck Sharp & Dohme Corp
8.2. Novartis AG
8.3. Pfizer Inc
8.4. Sanofi
8.5. Biodiem
8.6. Emergent Biosolutions Inc
8.7. F. Hoffmann-La Roche Ltd
8.8. GlaxoSmithKline plc
8.9. Abbott
8.10. CSL Limited

9. Research Methodology & Scope

9.1. Research Scope & Deliverables
9.1.1. Objectives of Study
9.1.2. Scope of Study
9.2. Sources of Data
9.2.1. Primary Data Sources
9.2.2. Secondary Data Sources
9.3. Research Methodology
9.3.1. Evaluation of Proposed Market
9.3.2. Identification of Data Sources
9.3.3. Assessment of Market Determinants
9.3.4. Data Collection
9.3.5. Data Validation & Analysis

List of Tables

Table 1: Global Influenza Vaccines Market, by Geography, 2019-2028 (In $ Million)
Table 2: Vendor Scorecard
Table 3: Global Influenza Vaccines Market, by Type, 2019-2028 (In $ Million)
Table 4: Global Influenza Vaccines Market, by Technology, 2019-2028 (In $ Million)
Table 5: Global Influenza Vaccines Market, by Age Group, 2019-2028 (In $ Million)
Table 6: Global Influenza Vaccines Market, by Delivery Mode, 2019-2028 (In $ Million)
Table 7: Global Influenza Vaccines Market, by Geography, 2019-2028 (In $ Million)
Table 8: North America Influenza Vaccines Market, by Country, 2019-2028 (In $ Million)
Table 9: North America Influenza Vaccines Market, by Type, 2019-2028 (In $ Million)
Table 10: North America Influenza Vaccines Market, by Technology, 2019-2028 (In $ Million)
Table 11: North America Influenza Vaccines Market, by Age Group, 2019-2028 (In $ Million)
Table 12: North America Influenza Vaccines Market, by Delivery Mode, 2019-2028 (In $ Million)
Table 13: Europe Influenza Vaccines Market, by Country, 2019-2028 (In $ Million)
Table 14: Europe Influenza Vaccines Market, by Type, 2019-2028 (In $ Million)
Table 15: Europe Influenza Vaccines Market, by Technology, 2019-2028 (In $ Million)
Table 16: Europe Influenza Vaccines Market, by Age Group, 2019-2028 (In $ Million)
Table 17: Europe Influenza Vaccines Market, by Delivery Mode, 2019-2028 (In $ Million)
Table 18: Asia-Pacific Influenza Vaccines Market, by Country, 2019-2028 (In $ Million)
Table 19: Asia-Pacific Influenza Vaccines Market, by Type, 2019-2028 (In $ Million)
Table 20: Asia-Pacific Influenza Vaccines Market, by Technology, 2019-2028 (In $ Million)
Table 21: Asia-Pacific Influenza Vaccines Market, by Age Group, 2019-2028 (In $ Million)
Table 22: Asia-Pacific Influenza Vaccines Market, by Delivery Mode, 2019-2028 (In $ Million)
Table 23: Latin America Influenza Vaccines Market, by Country, 2019-2028 (In $ Million)
Table 24: Latin America Influenza Vaccines Market, by Type, 2019-2028 (In $ Million)
Table 25: Latin America Influenza Vaccines Market, by Technology, 2019-2028 (In $ Million)
Table 26: Latin America Influenza Vaccines Market, by Age Group, 2019-2028 (In $ Million)
Table 27: Latin America Influenza Vaccines Market, by Delivery Mode, 2019-2028 (In $ Million)
Table 28: Middle East and Africa Influenza Vaccines Market, by Country, 2019-2028 (In $ Million)
Table 29: Middle East and Africa Influenza Vaccines Market, by Type, 2019-2028 (In $ Million)
Table 30: Middle East and Africa Influenza Vaccines Market, by Technology, 2019-2028 (In $ Million)
Table 31: Middle East and Africa Influenza Vaccines Market, by Age Group, 2019-2028 (In $ Million)
Table 32: Middle East and Africa Influenza Vaccines Market, by Delivery Mode, 2019-2028 (In $ Million)

List of Figures

Figure 1: Global Influenza Vaccines Market, by Source, 2019 & 2028 (In %)
Figure 2: Global Quadrivalent Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 3: Global Injection Delivery Model Market, 2019-2028 (In $ Million)
Figure 4: Global Cell-Based Technology Market, 2019-2028 (In $ Million)
Figure 5: Global Adult Age Group Market, 2019-2028 (In $ Million)
Figure 6: Porter's Five Force Analysis
Figure 7: Market Attractiveness Index
Figure 8: Global Influenza Vaccines Market, by Quadrivalent Vaccine, 2019-2028 (In $ Million)
Figure 9: Global Influenza Vaccines Market, by Trivalent Vaccines, 2019-2028 (In $ Million)
Figure 10: Global Influenza Vaccines Market, by Egg-Based Technology, 2019-2028 (In $ Million)
Figure 11: Global Influenza Vaccines Market, by Cell-Based Technology, 2019-2028 (In $ Million)
Figure 12: Global Influenza Vaccines Market, by Pediatric Age Group, 2019-2028 (In $ Million)
Figure 13: Global Influenza Vaccines Market, by Adult Age Group, 2019-2028 (In $ Million)
Figure 14: Global Influenza Vaccines Market, by Injection, 2019-2028 (In $ Million)
Figure 15: Global Influenza Vaccines Market, by Nasal Spray, 2019-2028 (In $ Million)
Figure 16: Global Influenza Vaccines Market, Regional Outlook, 2019 & 2028 (In %)
Figure 17: United States Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 18: Canada Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 19: United Kingdom Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 20: Germany Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 21: France Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 22: Spain Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 23: Italy Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 24: Russia Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 25: Rest of Europe Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 26: China Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 27: Japan Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 28: India Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 29: South Korea Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 30: Asean Countries Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 31: Australia & New Zealand Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 32: Rest of Asia-Pacific Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 33: Brazil Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 34: Mexico Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 35: Rest of Latin America Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 36: the United Arab Emirates Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 37: Turkey Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 38: Saudi Arabia Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 39: South Africa Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 40: Rest of Middle East & Africa Influenza Vaccines Market, 2019-2028 (In $ Million)